powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1114319191
Daniel Nohra Revilla
DO
Neurology
Orlando,
FL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 100006
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
901
Beneficiaries
—
Total drug cost
$608K
Distinct drugs
18
Brand share
65.4%
Top prescribed drugs
Ubrogepant
157 claims
Erenumab-Aooe
112 claims
Gabapentin
77 claims
Rimegepant Sulfate
73 claims
Memantine Hcl
68 claims
QUALITY · MIPS · 2024
Final MIPS score
79.9
Quality
61.2
Cost
71.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.21%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
91
Unique beneficiaries
—
Total services
10,107
Distinct HCPCS
5
Medicare payment
$59K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,241 Neurology providers in FL — top quintile (cohort median 598).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
77
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K